Diabetes and Heart Failure: Whats the Connection

Diabetes mellitus and heart failure are two common chronic conditions that frequently coexist, producing outcomes worse than either disease alone. This paper investigates how diabetes directly impairs the myocardium, leading to a distinct syndrome often termed diabetic cardiomyopathy, and examines the reciprocal influence of both disorders. Evidence from clinical and experimental studies highlights altered myocardial metabolism, oxidative stress, glycation pathways, calcium dysregulation, mitochondrial injury, inflammatory signaling, and autonomic imbalance as contributors to structural and functional decline. Analysis of pharmacological data shows that sodiumglucose cotransporter-2 inhibitors consistently improve outcomes across heart failure phenotypes, while glucagon-like peptide-1 receptor agonists offer benefits mainly in obesity-related HFpEF. By contrast, several older glucose-lowering drugs may worsen congestion or remain neutral in prognosis. The review concludes that diabetes and heart failure form a complex, self-reinforcing network, and that targeted treatment strategies grounded in mechanistic understanding are critical for advancing patient care and clinical outcomes.